Benefits of nintedanib continuation in systemic autoimmune rheumatic disease-related progressive pulmonary fibrosis: KEIO-SARD-ILD-cohort

Further Publications Immunology

Passive maternal immunity in children born to women with systemic autoimmune rheumatic disease - A case-control study

J Autoimmun

Mazzucato-Puchner A, Ramspeck H, Ritschl V, Stamm T, Kuczwara V, Szlatinay A, Mandl P, Blüml S, Haslacher H, Baranyi U, Falcone V, Aletaha D, Rosta K

doi: 10.1016/j.jaut.2025.103439

Autoimmune Disease

Outcomes of respiratory syncytial virus infection in patients with systemic autoimmune rheumatic disease

Semin Arthritis Rheum

Enns JP, Wang J, Jiang B, Srivatsan S, Kowalski EN, Wang X, Williams ZK, Qian G, Hanberg J, Johnson C, Negron M, Bade KJ, Saavedra A, Mueller KT, Vanni KMM, Kotton CN, Sparks JA, Wallace ZS, Patel NJ

doi: 10.1016/j.semarthrit.2025.152846

Autoimmune Disease

The development of a risk threshold to aid risk stratified approach to monitoring for haematological, hepatic and/or renal adverse drug reactions during established conventional synthetic DMARD treatment for systemic autoimmune rheumatic diseases: a RAND/UCLA Appropriateness Method consensus study

Rheumatology (Oxford)

Ablewhite J, Nakafero G, Almayahi A, Bechman K, Ahmed A, Davidson A, De Vere H, Dhillon E, Foulkes A, Gullick N, Heaton R, Hider S, Kyle S, Nowak K, Rose-Parfitt E, Ryan S, Tan SY, Wood N, Zebate G, Parsons K, Holmes J, Twohigg H, Reynolds JA, Mercer L, Galloway J, Abhishek A

doi: 10.1093/rheumatology/keag031

Autoimmune Disease

HLA alleles predisposing to autoimmunity are linked to impaired immunoregulation in patients with juvenile autoimmune liver disease and in their first-degree relatives

J Autoimmun

Wang P, Yuksel M, Gabeta S, Graham J, Hussain M, Blackmore LJ, Huang X, Hadzic D, Samyn M, Grammatikopoulos T, Heneghan M, Liberal R, Longhi MS, Mieli-Vergani G, Vergani D, Ma Y

doi: 10.1016/j.jaut.2025.103436

Rheumatoid Arthritis

Progressive interstitial lung disease associated with rheumatoid arthritis and abatacept: data from a multicenter cohort of 526 patients

Rheumatology (Oxford)

Serrano-Combarro A, Atienza-Mateo B, Martín-Gutierrez A, Ibarrola Paino L, Casafont-Solé I, Loarce-Martos J, Blanco-Madrigal JM, Ortega-Castro R, Mena-Vázquez N, Fernández-Díaz C, Loricera J, Ferrer D, Castañeda S, Blanco R, Spanish Collaborative Group of Interstitial Lung Disease Associated with Rheumatoid Arthritis

doi: 10.1093/rheumatology/keag023

Systemic Sclerosis

Efficacy and safety of rituximab versus intravenous cyclophosphamide for systemic sclerosis-associated interstitial lung disease: a retrospective cohort study

Arthritis Res Ther

Hiura R, Ayano M, Uchino A, Hiura J, Ueda N, Tanaka A, Yoshizawa S, Kawano S, Sagawa F, Ota SI, Hirata A, Fujimoto S, Nishimura N, Takaki-Kuwahara A, Kimoto Y, Akashi K, Niiro H

doi: 10.1186/s13075-025-03654-0

Systemic Lupus Erythematosus

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

Rheumatology (Oxford)

Nakanishi E, Matsushita M, Minowa K, Tada K, Kawamoto T, Kusaoi M, Amano H, Kon T, Morimoto S, Ikeda K, Suzuki S, Nozawa K, Yang KS, Matsudaira R, Katagiri A, Tsushima H, Urasaki W, Nojiri S, Yamaji K, Tamura N

doi: 10.1093/rheumatology/keaf349

Systemic Sclerosis

The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133)

Ann Rheum Dis

Petelytska L, Tofani L, Velauthapillai A, Dobrota R, Becker MO, Mihai C, Muraru S, Elhai M, Jordan S, Hachulla E, Müller-Ladner U, Siegert E, Allanore Y, Riemekasten G, Bergmann C, Becvar R, Solanki K, Anic B, Szabo I, Stamenkovic B, Distler J, Carreira PE, Cuomo G, Castellví I, Balbir-Gurman A, Airò P, Litinsky I, Saketkoo LA, Bertaccini B, Vonk MC, de Vries-Bouwstra J, Hoffmann-Vold AM, Matucci-Cerinic M, Distler O, Bruni C, EUSTAR collaborators

doi: 10.1016/j.ard.2025.12.008

Autoimmune Disease

New-onset Autoimmune Diseases in Patients with Prurigo Nodularis: A Global-federated Retrospective Cohort Study

Acta Derm Venereol

Chang HC, Chang CC, Chu YJ, Hsu WT, Li YF, Jhang YS, Su YJ, Chen SJ, Zuberbier T, Gau SY

doi: 10.2340/actadv.v105.43515

Related content

Passive maternal immunity in children born to women with systemic autoimmune rheumatic disease - A case-control study

Outcomes of respiratory syncytial virus infection in patients with systemic autoimmune rheumatic disease

The development of a risk threshold to aid risk stratified approach to monitoring for haematological, hepatic and/or renal adverse drug reactions during established conventional synthetic DMARD treatment for systemic autoimmune rheumatic diseases: a RAND/UCLA Appropriateness Method consensus study

HLA alleles predisposing to autoimmunity are linked to impaired immunoregulation in patients with juvenile autoimmune liver disease and in their first-degree relatives

Progressive interstitial lung disease associated with rheumatoid arthritis and abatacept: data from a multicenter cohort of 526 patients

Efficacy and safety of rituximab versus intravenous cyclophosphamide for systemic sclerosis-associated interstitial lung disease: a retrospective cohort study

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133)

New-onset Autoimmune Diseases in Patients with Prurigo Nodularis: A Global-federated Retrospective Cohort Study